Lv6
2110 积分 2021-12-16 加入
Pyoderma gangrenosum study pilot registry: The first step to a better understanding
12天前
已完结
Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator-controlled phase 3 trial
21天前
已完结
Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator-controlled phase 3 trial
21天前
已完结
Undervaccination and severe COVID-19 outcomes: meta-analysis of national cohort studies in England, Northern Ireland, Scotland, and Wales
21天前
已完结
Efficacy and Safety of Switching to Picankibart from Non-interleukin-23 Subunit p19 Inhibitors in Patients with Plaque Psoriasis: A Multicenter, Open-Label, Phase 2 Trial
25天前
已完结
Efficacy and Safety of Switching to Picankibart from Non-interleukin-23 Subunit p19 Inhibitors in Patients with Plaque Psoriasis: A Multicenter, Open-Label, Phase 2 Trial
25天前
已完结
Definitions of remission in psoriasis: a systematic literature review from the National Psoriasis Foundation
28天前
已完结
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
28天前
已完结
Characterization and treatment outcomes of biologic therapy in super-responders and biologic-refractory psoriasis patients: A single-center retrospective study in China
1个月前
已完结
Prevalence and characterization of treatment‐refractory psoriasis and super‐responders to biologic treatment: a nationwide study
1个月前
已完结
皖公网安备34019202002308
